← Back to Screener
Coeptis Therapeutics Holdings, Inc. Warrants (COEPW)
Price$0.01
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-72.44%
Price vs S&P 500 (4W)-28.04%
VGM Score42.76
All Metrics
Price vs S&P 500 (YTD)-6.92%
10-Day Avg Trading Volume0.51M
3-Month Avg Trading Volume0.08M
52-Week High$0.05
26-Week Price Return-64.98%
13-Week Price Return-19.38%
3-Month Return Std Dev128.08%
Year-to-Date Return-3.70%
5-Day Price Return4.00%
Month-to-Date Return-15.45%
Price vs S&P 500 (13W)-23.00%
Beta-1.84x
52-Week Low$0.01
mGradeC
vgmGradeC
Show chart for
Industry Peers — Finance Services(153)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
COEPWCoeptis Therapeutics Holdings, Inc. Warrants | — | — | C | $0.01 |
| AXPAmerican Express Company | D | B | B | $310.66 |
| NUNu Holdings Ltd. | D | B | C | $11.97 |
| MSTRStrategy Inc Common Stock Class A | D | D | D | $120.44 |
| COINCoinbase Global, Inc. Class A Common Stock | D | C | D | $152.40 |
| SYFSYNCHRONY FINANCIAL | B | C | B | $70.84 |
| SOFISoFi Technologies, Inc. Common Stock | D | B | C | $16.03 |
| CRCLCircle Internet Group, Inc. | D | C | C | $80.28 |
| IRENIREN Limited Ordinary Shares | F | B | B | $54.35 |
| WULFTeraWulf Inc. Common Stock | F | B | A | $24.00 |
| HUTHut 8 Corp. Common Stock | F | A | A | $112.24 |
About
Coeptis Therapeutics is a biopharmaceutical company developing cell therapies for CD38-related cancers. The company's pipeline includes multi-antigen CAR T technology (SNAP-CAR) licensed from the University of Pittsburgh, a CD38-targeting natural killer cell therapy (CD38-GEAR-NK), and companion diagnostics developed with VyGen-Bio and the Karolinska Institutet.